NFE2L2 and Cerebral ischemia: For example, treating rats with agomelatine after a cerebral ischemia, led to reduced ROS production in the brain, greater antioxidant properties, and less neuronal apoptosis because of an increase in nuclear factor erythroid 2-related factor 2 (NRF2)84.